The Joint British Diabetes Societies (JBDS) for Inpatient Care group was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and proposed standards of care within secondary care organisations’, with the overall aim of improving inpatient diabetes care through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.

The Joint British Diabetes Societies (JBDS) for Inpatient Care group was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and proposed standards of care within secondary care organisations’, with the overall aim of improving inpatient diabetes care through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.

The Joint British Diabetes Societies (JBDS) for Inpatient Care group was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and proposed standards of care within secondary care organisations’, with the overall aim of improving inpatient diabetes care through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.

Thanks to support from ABCD and others Total Pancreatectomy with Islet Autotransplantation (TPIAT) has been approved by NHS England for funding from April 2019 under ‘Highly Specialised Commissioning’.  A provider selection process will be held before then to identify a small network of specialised units that will undertake the procedure for NHS patients.

The announcement can be found HERE

NHS England  has recently published the document “Language  Matters – diabetes Language”.

The Joint British Diabetes Societies (JBDS) of which ABCD is an integral member, has informed us of the plans for Diabetic Medicine to devote the August issue to publish the in-patient guidelines and other important papers. This is to be welcomed and will make these very important guidelines to reach readers not only in UK but worldwide.

As you will be aware the Joint British Diabetes Society (JBDS) guideline for the use of Variable Rate Intravenous Insulin Infusion (VRIII) was published in late 2014 and we hope it has become firmly embedded in practice in acute trusts throughout the country.

Link to guideline HERE 

During surgery or other procedures under sedation or anaesthesia, the aim is to maintain normal glycaemic control with optimal hydration while preventing hypoglycaemia. These guidelines are based on the International Society of Paediatric and Adolescent Diabetes (ISPAD) clinical practice consensus guidelines. Modifications have been made in the light of recently published adult guidelines and from the guidelines published in the anaesthetic literature. They aim to ensure quality of patient care is standardised but individual units may make adjustments to fit with local practice.

Norfolk and Norwich University Hospitals NHS Foundation Trust have produced a guideline for the management of insulin pump therapy for children with Type 1 diabetes that covers the following: the process by which suitability for CSII will be determined; the responsibilities of the diabetes team and families, to facilitate effective management of CSII; criteria for discontinuing CSII where its use has not been effective in improving diabetes control and/or quality of life; guidance on management of sick day rules for patients on CSII; insulin pump failure